NCT07168694View on ClinicalTrials.gov

A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia

CompletedOBSERVATIONAL
Enrollment

606

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

September 26, 2024

Study Completion Date

September 26, 2024

Conditions
Secondary Progressive Multiple Sclerosis
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY